Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An XML-based interchange format for genotype-phenotype data.

M Whirl-Carrillo1, M Woon, C F Thorn

  • 1Department of Genetics, Stanford University, Stanford, California 94305-5444, USA.

Human Mutation
|November 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacogenetic information in Swiss drug labels - a systematic analysis.

The pharmacogenomics journal·2020
Same author

Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.

Clinical pharmacology and therapeutics·2017
Same author

New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine.

Clinical pharmacology and therapeutics·2017
Same author

Response to "Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped" - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole.

Clinical pharmacology and therapeutics·2017
Same author

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

Clinical pharmacology and therapeutics·2017
Same author

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.

Clinical pharmacology and therapeutics·2017
Same journal

RETRACTION: "Differential Effects of AKT1(p.E17K) Expression on Human Mammary Luminal Epithelial and Myoepithelial Cells".

Human mutation·2026
Same journal

Diagnostic Yield of Genome Sequencing in an Iranian Exome-Negative Autosomal-Recessive Intellectual Disability Cohort.

Human mutation·2026
Same journal

Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based Method.

Human mutation·2026
Same journal

Modeling the Effects of Single Nucleotide Polymorphisms (SNPs) on the Structure and Function of the Human <i>RET</i> Gene: An In Silico Study.

Human mutation·2026
Same journal

Driver Mutation Subtypes Differentially Shape Immune Evasion Landscapes in Melanoma: An AI-Driven Inflammatory Pathway Model Implicating CCNE1.

Human mutation·2026
Same journal

Comment on "When the Outcome Contains the Exposure: Methodological Limits of a Genome-Wide Cross-Trait Analysis of Type 2 Diabetes and MASLD".

Human mutation·2026
See all related articles

A new XML schema standardizes pharmacogenomic data exchange, enabling seamless transfer of genotype and phenotype information between databases and analysis tools. This facilitates broader research in personalized medicine and drug response.

Area of Science:

  • Genomics
  • Bioinformatics
  • Pharmacogenomics

Background:

  • High-throughput genotyping and phenotyping generate vast pharmacogenomic data.
  • Standardized formats are crucial for exchanging diverse biological information.
  • Existing data exchange methods lack comprehensive standardization for pharmacogenomic datasets.

Purpose of the Study:

  • To develop a standardized XML schema for pharmacogenomic data.
  • To facilitate the exchange of genotype and phenotype data between research systems.
  • To create a flexible schema accommodating diverse biological information.

Main Methods:

  • Developed a standardized XML schema for pharmacogenomic data.
  • Schema accommodates genes, drugs, diseases, experimental methods, sequences, subjects, and literature.

Related Experiment Videos

  • Created syntactic and semantic validators for data integrity.

    • Main Results:

    • The XML schema successfully facilitates pharmacogenomic data transfer.
    • PharmGKB has utilized the schema for over five years, processing extensive datasets.
    • The schema supports diverse data types including SNPs, subjects, and assays.

    Conclusions:

    • The developed XML schema provides a robust standard for pharmacogenomic data exchange.
    • The schema is broadly applicable beyond pharmacogenomics for genotype and phenotype data.
    • Validators ensure data accuracy and compliance with the established standard.